African Journal of Medical and Health Sciences

ORIGINAL ARTICLE
Year
: 2015  |  Volume : 14  |  Issue : 2  |  Page : 135--139

Clinicians«SQ» awareness on thromboprophylaxis in cancer-associated thrombosis


Hannah E Omunakwe1, Onyeanunam Ngozi Ekeke2, Kaladada I Korubo3 
1 Department of Pathology, Braithwaite Memorial Specialist Hospital, Port Harcourt, Nigeria
2 Department of Surgery, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria
3 Department of Haematology, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria

Correspondence Address:
Hannah E Omunakwe
Haematology Unit, Pathology Department, Braithwaite Memorial Specialist Hospital, Port Harcourt, Rivers State
Nigeria

Context: Venous thromboembolism is a significant cause of morbidity and mortality in cancer patients. Awareness of patients at risk will enable clinicians proffer thromboprophylaxis promptly and thus reduce morbidity and mortality. Aims: The aim of the study is to evaluate the clinicians«SQ» awareness and practice of thromboprophylaxis in cancer patients. Materials and Methods: A descriptive questionnaire-based survey of clinicians in the University of Port Harcourt Teaching Hospital. Statistical analysis used: The Statistical analysis was done using SPSS 17.0. Results: Ninety-four clinicians responded (78.33%). Forty (42.55%) could define Venous thromboembolism (VTE) appropriately. Fifty-seven (60.63%) clinicians saw 1-6 cancer patients monthly and majority; 84 (89.36%) said cancer patients were at higher risk of VTE than noncancer patients. The most commonly cited risk factors for cancer-associated thrombosis (CAT) were the site of the tumor (98.9%), surgery (76%), body mass index (76%). Thirty-seven (39.36%) reported offering some form of thromboprophylaxis to their cancer patients. Low molecular weight heparin was most prescribed; by 24 (64.87%) respondents. Fifty-four (57.45%) of the respondents had no idea of the effect of heparins on tumor progression. Conclusions: The awareness of CAT and the importance of thromboprophylaxis amongst our clinicians is low.


How to cite this article:
Omunakwe HE, Ekeke ON, Korubo KI. Clinicians' awareness on thromboprophylaxis in cancer-associated thrombosis.Afr J Med Health Sci 2015;14:135-139


How to cite this URL:
Omunakwe HE, Ekeke ON, Korubo KI. Clinicians' awareness on thromboprophylaxis in cancer-associated thrombosis. Afr J Med Health Sci [serial online] 2015 [cited 2021 Apr 21 ];14:135-139
Available from: http://www.ajmhs.org/article.asp?issn=2384-5589;year=2015;volume=14;issue=2;spage=135;epage=139;aulast=Omunakwe;type=0